{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T12:52:10Z","timestamp":1790859130919,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,4,9]],"date-time":"2021-04-09T00:00:00Z","timestamp":1617926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,4,9]],"date-time":"2021-04-09T00:00:00Z","timestamp":1617926400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol. Sin."],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1007\/s12250-021-00369-9","type":"journal-article","created":{"date-parts":[[2021,4,9]],"date-time":"2021-04-09T10:02:46Z","timestamp":1617962566000},"page":"890-900","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Construction of Non-infectious SARS-CoV-2 Replicons and Their Application in Drug Evaluation"],"prefix":"10.1016","volume":"36","author":[{"given":"Bei","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chongyang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobo","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8851-4246","authenticated-orcid":false,"given":"Zhendong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1116-4559","authenticated-orcid":false,"given":"Jianwei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4887-2671","authenticated-orcid":false,"given":"He","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","published-online":{"date-parts":[[2021,4,9]]},"reference":[{"key":"369_CR1","doi-asserted-by":"publisher","first-page":"5516","DOI":"10.1073\/pnas.97.10.5516","volume":"97","author":"F Almaz\u00e1n","year":"2000","unstructured":"Almaz\u00e1n F, Gonz\u00e1lez JM, P\u00e9nzes Z, Izeta A, Calvo E, Plana-Dur\u00e1n J, Enjuanes L (2000) Engineering the largest RNA virus genome as an infectious bacterial artificial chromosome. Proc Natl Acad Sci USA 97:5516\u20135521","journal-title":"Proc Natl Acad Sci USA"},{"key":"369_CR2","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.virusres.2014.05.026","volume":"189","author":"F Almaz\u00e1n","year":"2014","unstructured":"Almaz\u00e1n F, Sola I, Zu\u00f1iga S, Marquez-Jurado S, Morales L, Becares M, Enjuanes L (2014) Coronavirus reverse genetic systems: infectious clones and replicons. Virus Res 189:262\u2013270","journal-title":"Virus Res"},{"key":"369_CR3","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.antiviral.2003.08.016","volume":"60","author":"R Bartenschlager","year":"2003","unstructured":"Bartenschlager R, Kaul A, Sparacio S (2003) Replication of the hepatitis C virus in cell culture. Antivir Res 60:91\u2013102","journal-title":"Antivir Res"},{"key":"369_CR4","doi-asserted-by":"publisher","first-page":"104786","DOI":"10.1016\/j.antiviral.2020.104786","volume":"178","author":"KT Choy","year":"2020","unstructured":"Choy KT, Wong AY, Kaewpreedee P, Sia SF, Chen D, Hui K, Chu D, Chan M, Cheung PP, Huang X, Peiris M, Yen HL (2020) Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro. Antivir Res 178:104786","journal-title":"Antivir Res"},{"key":"369_CR5","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1038\/s41564-020-0695-z","volume":"5","author":"Coronaviridae Study Group of the International Committee on Taxonomy of Viruses","year":"2020","unstructured":"Coronaviridae Study Group of the International Committee on Taxonomy of Viruses (2020) The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol 5:536\u2013544","journal-title":"Nat Microbiol"},{"key":"369_CR6","doi-asserted-by":"publisher","first-page":"6771","DOI":"10.1073\/pnas.1922083117","volume":"117","author":"E de Wit","year":"2020","unstructured":"de Wit E, Feldmann F, Cronin J, Jordan R, Okumura A, Thomas T, Scott D, Cihlar T, Feldmann H (2020) Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection. Proc Natl Acad Sci USA 117:6771\u20136776","journal-title":"Proc Natl Acad Sci USA"},{"key":"369_CR7","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1056\/NEJMoa030747","volume":"348","author":"C Drosten","year":"2003","unstructured":"Drosten C, G\u00fcnther S, Preiser W, van der Werf S, Brodt HR, Becker S, Rabenau H, Panning M, Kolesnikova L, Fouchier RA, Berger A, Burgui\u00e8re AM (2003) Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med 348:1967\u20131976","journal-title":"N Engl J Med"},{"key":"369_CR8","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.virol.2006.10.016","volume":"360","author":"F Ge","year":"2007","unstructured":"Ge F, Luo Y, Liew PX, Hung E (2007) Derivation of a novel SARS-coronavirus replicon cell line and its application for anti-SARS drug screening. Virology 360:150\u2013158","journal-title":"Virology"},{"key":"369_CR9","doi-asserted-by":"publisher","first-page":"3215","DOI":"10.2147\/DDDT.S261154","volume":"14","author":"SM Hashemian","year":"2020","unstructured":"Hashemian SM, Farhadi T, Velayati AA (2020) A review on remdesivir: a possible promising agent for the treatment of COVID-19. Drug Des Dev Ther 14:3215\u20133222","journal-title":"Drug Des Dev Ther"},{"key":"369_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/095632020501600101","volume":"16","author":"N Horscroft","year":"2005","unstructured":"Horscroft N, Lai VC, Cheney W, Yao N, Wu JZ, Hong Z, Zhong W (2005) Replicon cell culture system as a valuable tool in antiviral drug discovery against hepatitis C virus. Antivir Chem Chemother 16:1\u201312","journal-title":"Antivir Chem Chemother"},{"key":"369_CR11","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.cell.2020.05.042","volume":"182","author":"YJ Hou","year":"2020","unstructured":"Hou YJ, Okuda K, Edwards CE, Martinez DR, Asakura T, Dinnon KR, Kato T, Lee RE, Yount BL, Mascenik TM, Chen G, Olivier KN, Ghio A, Tse LV, Leist SR, Gralinski LE, Sch\u00e4fer A, Dang H, Gilmore R, Nakano S, Sun L, Fulcher ML, Livraghi-Butrico A, Nicely NI, Cameron M, Cameron C, Kelvin DJ, de Silva A, Margolis DM, Markmann A, Bartelt L, Zumwalt R, Martinez FJ, Salvatore SP, Borczuk A, Tata PR, Sontake V, Kimple A, Jaspers I, O\u2019Neal WK, Randell SH, Boucher RC, Baric RS (2020) SARS-CoV-2 reverse genetics reveals a variable infection gradient in the respiratory tract. Cell 182:429\u2013446","journal-title":"Cell"},{"key":"369_CR12","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395:497\u2013506","journal-title":"Lancet"},{"key":"369_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1006\/viro.1995.1123","volume":"208","author":"JC Kim","year":"1995","unstructured":"Kim JC, Spence RA, Currier PF, Lu X, Denison MR (1995) Coronavirus protein processing and RNA synthesis is inhibited by the cysteine proteinase inhibitor E64d. Virology 208:1\u20138","journal-title":"Virology"},{"key":"369_CR14","doi-asserted-by":"publisher","DOI":"10.1101\/2020.08.28.267567","author":"T Kotaki","year":"2020","unstructured":"Kotaki T, Xie X, Shi P, Kameoka M (2020) A PCR amplicon-based SARS-CoV-2 replicon for antiviral screening. bioRxiv. https:\/\/doi.org\/10.1101\/2020.08.28.267567","journal-title":"bioRxiv"},{"key":"369_CR15","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.jviromet.2016.07.022","volume":"236","author":"AM Nikiforuk","year":"2016","unstructured":"Nikiforuk AM, Leung A, Cook B, Court DA, Kobasa D, Theriault SS (2016) Rapid one-step construction of a Middle East Respiratory Syndrome (MERS-CoV) infectious clone system by homologous recombination. J Virol Methods 236:178\u2013183","journal-title":"J Virol Methods"},{"key":"369_CR16","doi-asserted-by":"publisher","first-page":"107940","DOI":"10.1016\/j.celrep.2020.107940","volume":"32","author":"AJ Pruijssers","year":"2020","unstructured":"Pruijssers AJ, George AS, Sch\u00e4fer A, Leist SR, Gralinksi LE, Dinnon KR, Yount BL, Agostini ML, Stevens LJ, Chappell JD, Lu X, Hughes TM, Gully K, Martinez DR, Brown AJ, Graham RL, Perry JK, Du Pont V, Pitts J, Ma B, Babusis D, Murakami E, Feng JY, Bilello JP, Porter DP, Cihlar T, Baric RS, Denison MR, Sheahan TP (2020) Remdesivir inhibits SARS-CoV-2 in human lung cells and chimeric SARS-CoV expressing the SARS-CoV-2 RNA polymerase in mice. Cell Rep 32:107940","journal-title":"Cell Rep"},{"key":"369_CR17","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1097\/CM9.0000000000000722","volume":"133","author":"LL Ren","year":"2020","unstructured":"Ren LL, Wang YM, Wu ZQ, Xiang ZC, Guo L, Xu T, Jiang YZ, Xiong Y, Li YJ, Li XW, Li H, Fan GH, Gu XY, Xiao Y, Gao H, Xu JY, Yang F, Wang XM, Wu C, Chen L, Liu YW, Liu B, Yang J, Wang XR, Dong J, Li L, Huang CL, Zhao JP, Hu Y, Cheng ZS, Liu LL, Qian ZH, Qin C, Jin Q, Cao B, Wang JW (2020) Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study. Chin Med J (Engl) 133:1015\u20131024","journal-title":"Chin Med J (Engl)"},{"key":"369_CR18","doi-asserted-by":"publisher","first-page":"aal3653","DOI":"10.1126\/scitranslmed.aal3653","volume":"9","author":"TP Sheahan","year":"2017","unstructured":"Sheahan TP, Sims AC, Graham RL, Menachery VD, Gralinski LE, Case JB, Leist SR, Pyrc K, Feng JY, Trantcheva I, Bannister R, Park Y, Babusis D, Clarke MO, Mackman RL, Spahn JE, Palmiotti CA, Siegel D, Ray AS, Cihlar T, Jordan R, Denison MR, Baric RS (2017) Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses. Sci Transl Med 9:aal3653","journal-title":"Sci Transl Med"},{"key":"369_CR19","doi-asserted-by":"publisher","DOI":"10.1101\/2020.09.18.302901","author":"M Shi","year":"2020","unstructured":"Shi M, Wang L, Fontana P, Vora S, Zhang Y, Fu TM, Lieberman J, Wu H (2020) SARS-CoV-2 Nsp1 suppresseshost but not viral translation through a bipartite mechanism. bioRxiv. https:\/\/doi.org\/10.1101\/2020.09.18.302901","journal-title":"bioRxiv"},{"key":"369_CR20","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/s41586-020-2294-9","volume":"582","author":"NTT Thi","year":"2020","unstructured":"Thi NTT, Labroussaa F, Ebert N, V\u2019Kovski P, Stalder H, Portmann J, Kelly J, Steiner S, Holwerda M, Kratzel A, Gultom M, Schmied K, Laloli L, H\u00fcsser L, Wider M, Pfaender S, Hirt D, Cipp\u00e0 V, Crespo-Pomar S, Schr\u00f6der S, Muth D, Niemeyer D, Corman VM, M\u00fcller MA, Drosten C, Dijkman R, Jores J, Thiel V (2020) Rapid reconstruction of SARS-CoV-2 using a synthetic genomics platform. Nature 582:561\u2013565","journal-title":"Nature"},{"key":"369_CR21","first-page":"199","volume":"287","author":"V Thiel","year":"2005","unstructured":"Thiel V, Siddell SG (2005) Reverse genetics of coronaviruses using vaccinia virus vectors. Curr Top Microbiol Immunol 287:199\u2013227","journal-title":"Curr Top Microbiol Immunol"},{"key":"369_CR22","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.bbrc.2008.06.129","volume":"374","author":"JM Wang","year":"2008","unstructured":"Wang JM, Wang LF, Shi ZL (2008) Construction of a non-infectious SARS coronavirus replicon for application in drug screening and analysis of viral protein function. Biochem Biophys Res Commun 374:138\u2013142","journal-title":"Biochem Biophys Res Commun"},{"key":"369_CR23","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","volume":"30","author":"M Wang","year":"2020","unstructured":"Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M, Shi Z, Hu Z, Zhong W, Xiao G (2020) Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res 30:269\u2013271","journal-title":"Cell Res"},{"key":"369_CR24","doi-asserted-by":"publisher","first-page":"108234","DOI":"10.1016\/j.celrep.2020.108234","volume":"33","author":"H Xia","year":"2020","unstructured":"Xia H, Cao Z, Xie X, Zhang X, Chen JY, Wang H, Menachery VD, Rajsbaum R, Shi PY (2020) Evasion of type I interferon by SARS-CoV-2. Cell Rep 33:108234","journal-title":"Cell Rep"},{"key":"369_CR25","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.chom.2020.04.004","volume":"27","author":"X Xie","year":"2020","unstructured":"Xie X, Muruato A, Lokugamage KG, Narayanan K, Zhang X, Zou J, Liu J, Schindewolf C, Bopp NE, Aguilar PV, Plante KS, Weaver SC, Makino S, LeDuc JW, Menachery VD, Shi PY (2020) An infectious cDNA clone of SARS-CoV-2. Cell Host Microbe 27:841\u2013848","journal-title":"Cell Host Microbe"},{"key":"369_CR26","doi-asserted-by":"publisher","first-page":"10600","DOI":"10.1128\/JVI.74.22.10600-10611.2000","volume":"74","author":"B Yount","year":"2000","unstructured":"Yount B, Curtis KM, Baric RS (2000) Strategy for systematic assembly of large RNA and DNA genomes: transmissible gastroenteritis virus model. J Virol 74:10600\u201310611","journal-title":"J Virol"},{"key":"369_CR27","doi-asserted-by":"publisher","first-page":"12995","DOI":"10.1073\/pnas.1735582100","volume":"100","author":"B Yount","year":"2003","unstructured":"Yount B, Curtis KM, Fritz EA, Hensley LE, Jahrling PB, Prentice E, Denison MR, Geisbert TW, Baric RS (2003) Reverse genetics with a full-length infectious cDNA of severe acute respiratory syndrome coronavirus. Proc Natl Acad Sci USA 100:12995\u201313000","journal-title":"Proc Natl Acad Sci USA"},{"key":"369_CR28","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1016\/j.molcel.2020.10.034","volume":"80","author":"S Yuan","year":"2020","unstructured":"Yuan S, Peng L, Park JJ, Hu Y, Devarkar SC, Dong MB, Shen Q, Wu S, Chen S, Lomakin IB, Xiong Y (2020) Nonstructural protein 1 of SARS-CoV-2 is a potent pathogenicity factor redirecting host protein synthesis machinery toward viral RNA. Mol Cell 80:1055\u20131066","journal-title":"Mol Cell"},{"key":"369_CR29","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1056\/NEJMoa1211721","volume":"367","author":"AM Zaki","year":"2012","unstructured":"Zaki AM, van Boheemen S, Bestebroer TM, Osterhaus AD, Fouchier RA (2012) Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med 367:1814\u20131820","journal-title":"N Engl J Med"},{"key":"369_CR30","doi-asserted-by":"publisher","first-page":"104974","DOI":"10.1016\/j.antiviral.2020.104974","volume":"185","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Song W, Chen S, Yuan Z, Yi Z (2020) A bacterial artificial chromosome (BAC)-vectored noninfectious replicon of SARS-CoV-2. Antivir Res 185:104974","journal-title":"Antivir Res"},{"key":"369_CR31","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","volume":"579","author":"P Zhou","year":"2020","unstructured":"Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, Si HR, Zhu Y, Li B, Huang CL, Chen HD, Chen J, Luo Y, Guo H, Jiang RD, Liu MQ, Chen Y, Shen XR, Wang X, Zheng XS, Zhao K, Chen QJ, Deng F, Liu LL, Yan B, Zhan FX, Wang YY, Xiao GF, Shi ZL (2020) A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579:270\u2013273","journal-title":"Nature"}],"container-title":["Virologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12250-021-00369-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12250-021-00369-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12250-021-00369-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T01:39:59Z","timestamp":1641260399000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12250-021-00369-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,9]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["369"],"URL":"https:\/\/doi.org\/10.1007\/s12250-021-00369-9","relation":{},"ISSN":["1674-0769","1995-820X"],"issn-type":[{"value":"1674-0769","type":"print"},{"value":"1995-820X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,9]]},"assertion":[{"value":"7 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"A patent application has been filed on 13 October 2020 on SARS-CoV-2 replicon construction (China Patent Application No. 202011091157.1).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Animal and Human Rights Statement"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}